HR Execs on the Move

Nuwellis

www.nuwellis.com

 
We are Nuwellis, (Nasdaq: NUWE) formerly CHF Solutions. Our solutions go beyond chronic heart failure, so we`ve rebranded to reflect our therapeutic focus areas: heart failure, critical care, and pediatric fluid imbalance. We are a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. Our Aquadex SmartFlow® System gently removes fluid from adult and pediatric patients weighing 20 kg or more. Nuwellis consists of a purpose-driven team that puts patients and their providers at the center of everything we do. This is the new well. And for those whose lives ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.nuwellis.com
  • 12988 Valley View Road
    Eden Prairie, MN USA 55344
  • Phone: 952.345.4200

Executives

Name Title Contact Details
Rob Scott
Chief Financial Officer Profile
Lynn Blake
Chief Financial Officer Profile
Lynn Blake
Chief Financial Officer Profile
George Montague
Chief Financial Officer Profile

Similar Companies

Kab Dental

Kab Dental is a Sterling Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Dental Partners, Inc.

American Dental Partners, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

About Medical

About Medical is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.

Burlington Pharmacy Healthcare

Burlington Pharmacy Healthcare is a Burlington, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.